Molecular Pathways: Targeting DNA Repair Pathway Defects Enriched in Metastasis

Area of Science:

• Genetics
• Molecular Biology
• Oncology

Background:

• Maintaining genome integrity is crucial for preventing cellular abnormalities.
• DNA damage repair (DDR) pathways correct errors, but their dysregulation can lead to cancer and neurodegenerative diseases.

Purpose of the Study:

• To investigate the role of DNA repair pathway defects in cancer metastasis.
• To explore the therapeutic potential of targeting DNA repair deficiencies in advanced cancers.

Main Methods:

• Analysis of human metastasis specimens to identify defects in DDR regulators.
• Review of existing evidence on the function of TP53 and PARP in DNA damage response.
• Evaluation of therapeutic strategies, including PARP inhibition, in cancer treatment.

Main Results:

• Defects in key DDR regulators are frequently observed in human metastasis.
• TP53 protein and PARP enzyme family are critical regulators of DNA damage response checkpoints.
• PARP inhibition demonstrates clinical efficacy in subsets of patients with ovarian and prostate cancers, including those with metastatic disease.

Conclusions:

• Defects in DNA repair pathways are implicated as a critical step in cancer metastasis.
• Targeting DNA repair-deficient tumors offers a promising therapeutic strategy for advanced cancers.
• Exploiting differences between normal and cancer cells presents new avenues for treating advanced and metastatic diseases.